Upgrades by major financial institutions like Citigroup generally lead to positive short-term price movements due to increased investor confidence and perceived value. The significant raise in price target from $80 to $95 suggests a strong bullish outlook on Hologic by Citigroup, likely influencing investor sentiment and potentially driving the stock price up in the short term.